The purpose of the R03 Program is to enhance the capability of NCATS CTSA Program KL2 scholars and recipients of diversity and re-entry supplements supported by the CTSA Program to conduct research as they complete the transition to fully independent academic translational scientists. These grants will support different clinical and translational science research projects, including pilot and feasibility studies; secondary data analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.
Application budgets are limited to direct costs up to $50,000 per year for a maximum period of 2 years.
First due date is March 26, 2021. See details here.